Cargando…
Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews wi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859922/ https://www.ncbi.nlm.nih.gov/pubmed/35906435 http://dx.doi.org/10.1007/s10597-022-01012-x |
_version_ | 1784874466537373696 |
---|---|
author | Tarn, Derjung M. Shih, Kevin J. Ober, Allison J. Hunter, Sarah B. Watkins, Katherine E. Martinez, Jeremy Montero, Alanna McCreary, Michael Leamon, Isabel Sheehe, John Bromley, Elizabeth |
author_facet | Tarn, Derjung M. Shih, Kevin J. Ober, Allison J. Hunter, Sarah B. Watkins, Katherine E. Martinez, Jeremy Montero, Alanna McCreary, Michael Leamon, Isabel Sheehe, John Bromley, Elizabeth |
author_sort | Tarn, Derjung M. |
collection | PubMed |
description | Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included: perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone/methadone clinics; and viewing MOUD use as “cheating”. Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings. |
format | Online Article Text |
id | pubmed-9859922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-98599222023-01-22 Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness Tarn, Derjung M. Shih, Kevin J. Ober, Allison J. Hunter, Sarah B. Watkins, Katherine E. Martinez, Jeremy Montero, Alanna McCreary, Michael Leamon, Isabel Sheehe, John Bromley, Elizabeth Community Ment Health J Original Paper Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included: perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone/methadone clinics; and viewing MOUD use as “cheating”. Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings. Springer US 2022-07-29 2023 /pmc/articles/PMC9859922/ /pubmed/35906435 http://dx.doi.org/10.1007/s10597-022-01012-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Tarn, Derjung M. Shih, Kevin J. Ober, Allison J. Hunter, Sarah B. Watkins, Katherine E. Martinez, Jeremy Montero, Alanna McCreary, Michael Leamon, Isabel Sheehe, John Bromley, Elizabeth Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness |
title | Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness |
title_full | Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness |
title_fullStr | Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness |
title_full_unstemmed | Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness |
title_short | Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness |
title_sort | perspectives regarding medications for opioid use disorder among individuals with mental illness |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859922/ https://www.ncbi.nlm.nih.gov/pubmed/35906435 http://dx.doi.org/10.1007/s10597-022-01012-x |
work_keys_str_mv | AT tarnderjungm perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT shihkevinj perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT oberallisonj perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT huntersarahb perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT watkinskatherinee perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT martinezjeremy perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT monteroalanna perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT mccrearymichael perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT leamonisabel perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT sheehejohn perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness AT bromleyelizabeth perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness |